NL-OMON22493招募中不适用
The effects of the proton pump inhibitor esomeprazole on the bioavailability of afatinib (Giotrif®) in patients with non-small cell lung cancer (NSCLC) 'the BIO-GIO study'
Erasmus MC Rotterdam0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age ≥ 18 years
- •2. Histological or cytological confirmed diagnosis of EGFR-mutated NSCLC
排除标准
- •1. Pregnant or lactating patients.
- •2. Patients with known impaired drug absorption (e.g. gastrectomy and achlorhydria)
研究者
相似试验
招募中
不适用
COCA studyNL-OMON27946ErasmusMC Cancer Institute22
进行中（未招募）
1 期
The effects of the proton pump inhibitor esomeprazole alone or in combination with Coca-Cola on the absorption of Capecitabine in patients with cancer 'the COCA study'Colorectal carcinoma or other solid tumoursEUCTR2017-004465-27-NLErasmus MC Cancer Institute28
进行中（未招募）
1 期
The effects of the proton pump inhibitor esomeprazole on the bioavailability of afatinib (Giotrif®) in patients with lung cancer 'the BIO-GIO study'EUCTR2017-001284-20-NLErasmus MC Cancer Institute
进行中（未招募）
1 期
The effects of the proton pump inhibitor esomeprazole on the bioavailability of regorafenibEUCTR2015-005784-17-NLErasmus MC cancer institute14
招募中
不适用
The effects of the proton pump inhibitor esomeprazole on the bioavailability of afatinib (Giotrif®) in patients with non-small cell lung cancer (NSCLC) 'the BIO-GIO study'NL-OMON45272Erasmus MC, Universitair Medisch Centrum Rotterdam28